(Research Triangle Park, N.C.)

Global intellectual property leader Murgitroyd & Company is reporting a 50 percent increase in revenues at the company’s U.S. operation, which recorded sales of $8.4m in the 2009-2010 fiscal year compared with $5.6m in the preceding year. The U.S. market makes up 20 percent of the revenue for the entire company.

Accurate and complete expiry information now available with GenericsWeb Pipeline Scope

Finally, the generics industry has fast access to reliable key patent, SPC and data protection expiry information. Pipeline Scope, the latest release from industry experts GenericsWeb provides accurate and complete data for over 1400 INNs, across 37 countries, delivered through an interface that is easy to use and interpret.

FDA Announces Measures to Improve Generic Drug Access

The Food and Drug Administration (FDA) im March 2004 announced that it will provide more information to the public to help generic drug applicants determine if they are eligible for 180-day marketing exclusivity for their products. This period of marketing exclusivity is generally provided to the first generic drug that challenges a patent for the innovator product.

 Pirates and Corsairs - The difficult equation Pharma-Parallel Trade

“In the legal debate (…), with a little bit of imagination, the undertakings who dedicate themselves to parallel trade could be compared with the pirates and those who defend their intellectual property rights could be compared with the corsairs, who received the “corsair patent” from their Government to attack the ships of the enemy countries.

The continuing battle over Atorvastatin (Lipitor®)

In 2006, Pfizer’s product Lipitor (Atorvastatin) attained sales of US$ 11.7 billion. This was down by 3.6% from the figure for 2005, which disappointed Pfizer but still left it with enough turnover to make it a very attractive target for generic copies.

Biosimilars – inflated expectations?

It was the same Senator Waxman who cooperated in 1984 with Senator Hatch to introduce what became known as the Hatch-Waxman Act to introduce a simplified method of registration for generics.

World's largest patent database is now online

More than 63 million patent documents from 80 patent organisations worldwide can be searched via the International Patent Documentation Data Base, (INPADOCDB). It was created by merging and revising two existing databases of the European Patent Office (EPO).

Novel Approches about Semisolid Dosage Forms  

The new access in semisolid dosage forms by adding or applying some new approaches to improve them from bioavailability, efficacy, drug dosing  cost etc and  also techniques which may be launched recently, but not widely used.